Physician profile
Robert N Spivack
NPI 1568409753
$22,993.17
in general payments reported to CMS, 2019-2025
15 companies · $4,050 in 2025
The $4,050 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,234 · 2020: $394 · 2021: $947 · 2022: $1,504 · 2023: $3,718 · 2024: $9,146 · 2025: $4,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,303 · Travel and Lodging: $4,839 · Food and Beverage: $4,447 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,310 · Entertainment: $15.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,302.50 |
| Travel and Lodging | $4,839.46 |
| Food and Beverage | $4,446.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,310.00 |
| Entertainment | $15.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $17,359.69 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $2,633.76 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $1,717.17 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $454.07 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $204.63 | 2021-2023 | Cequa |
| Coopervision INC. | $203.84 | 2019-2022 | |
| Genzyme Corporation | $106.63 | 2024 | |
| Rxsight INC | $99.03 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Allergan, INC. | $92.25 | 2022 | |
| Abb Con-Cise Optical Group LLC | $26.41 | 2019-2020 | |
| Plexus Optix, INC. | $24.91 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.49 | 2021-2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Optos, INC. | $15.30 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Spivack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.